The CDMO’s Module 1 commercial production facility to be operational by summer 2026 Hyderabad, March 9th 2026: Neuland Laboratories  will open its new commercial peptide facility in the summer of 2026 ...

The breakthrough could simplify the production of complex proteins used in cancer immunotherapy and other advanced medicines ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...

Summary: Blockbuster weight-loss drugs like semaglutide (Wegovy/Ozempic) and liraglutide (Saxenda) have transformed metabolic health, but we are only just beginning to understand where they work in ...

Today Technomark Life Sciences ( and MAX BioPharma ( announced their collaboration in the development of MAX BioPharma's oxysterol drug candidate, Oxy210, for targeting ...

Many of the key proteins for modern medicine and science are poorly soluble. These include numerous signalling proteins and protein hormones, as well ...

LOS ANGELES, CA / ACCESS Newswire / March 10, 2026 / Today Technomark Life Sciences ( and MAX BioPharma ( announced their collaboration in the development of MAX ...